̽»¨Ö±²¥

Members have been recognised for their outstanding contribution to society

Professor Patrick Chinnery, an expert in diseases that affect mitochondria – the ‘batteries’ that power our cells – has been appointed as Professor of Neurology and Head of the Department of Clinical Neurosciences at the ̽»¨Ö±²¥ of Cambridge. He will take up his appointment on 1 October.

Critical insight provided into the disease mechanisms behind multiple sclerosis.

̽»¨Ö±²¥path from innovation to impact can be long and complex. Here we describe the 30-year journey behind the development of a drug now being used to treat multiple sclerosis.

Cambridge neurologists have shown that an antibody used to treat leukaemia also limits and repairs the damage in multiple sclerosis.